Related references
Note: Only part of the references are listed.Chemistry and anti-herpes simplex virus type 1 evaluation of 4-substituted-1H-1,2,3-triazole-nitroxyl-linked hybrids
Anna C. Cunha et al.
MOLECULAR DIVERSITY (2021)
Novel Insights to Enhance Therapeutics With Acyclovir in the Management of Herpes Simplex Encephalitis
Maria Silvia Gurgel Assis et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster
Naoko Shoji et al.
JOURNAL OF DERMATOLOGY (2020)
Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues
Xiao Jia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Impacts of Genome-Wide Analyses on Our Understanding of Human Herpesvirus Diversity and Evolution
Daniel W. Renner et al.
JOURNAL OF VIROLOGY (2018)
Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells
Dominique B. Figueroa et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
Katherine L. Seley-Radtke et al.
ANTIVIRAL RESEARCH (2018)
Drug-resistant cytomegalovirus: clinical implications of specific mutations
Raymund R. Razonable
CURRENT OPINION IN ORGAN TRANSPLANTATION (2018)
Clinical-features analysis on 926 patients with virological breakthrough in chronic hepatitis B receiving nucleos(t)ide analogues
Cheng Huang et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
Emma D. Deeks
DRUGS (2018)
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial
Marie-Laure Chaix et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor
Misako Yajima et al.
ANTIVIRAL RESEARCH (2017)
Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects
Arianna Mareri et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2016)
Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA
Ashwani Kumar Vashishtha et al.
BIOCHEMISTRY (2016)
HSV antivirals - current and future treatment options
Alexander Birkmann et al.
CURRENT OPINION IN VIROLOGY (2016)
A comprehensive insight on ocular pharmacokinetics
Vibhuti Agrahari et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2016)
Exposure-dependent incorporation of trifluridine into DNA of tumors and white blood cells in tumor-bearing mouse
Fumiaki Yamashita et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Purine Analogues as Kinase Inhibitors: A Review
Sahil Sharma et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2015)
Daily Oral Tenofovir and Emtricitabine-Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1-Uninfected Men and Women A Subgroup Analysis of a Randomized Trial
Connie Celum et al.
ANNALS OF INTERNAL MEDICINE (2014)
Cytomegalovirus
Paul Griffiths et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Nelfinavir Inhibits Maturation and Export of Herpes Simplex Virus 1
Nene N. Kalu et al.
JOURNAL OF VIROLOGY (2014)
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
Jared M. Baeten et al.
LANCET INFECTIOUS DISEASES (2014)
Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men
Julia L. Marcus et al.
PLOS ONE (2014)
Human Valacyclovir Hydrolase/Biphenyl Hydrolase-Like Protein Is a Highly Efficient Homocysteine Thiolactonase
Judit Marsillach et al.
PLOS ONE (2014)
Acquired Fanconi Syndrome Associated With Prolonged Adefovir Dipivoxil Therapy in a Chronic Hepatitis B Patient
Siu-tong Law et al.
AMERICAN JOURNAL OF THERAPEUTICS (2013)
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
Kai Lin et al.
ANTIVIRAL RESEARCH (2013)
Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus
Hugh J. Field et al.
DRUG RESISTANCE UPDATES (2011)
DNA polymerases as therapeutic targets
Anthony J. Berdis
BIOCHEMISTRY (2008)
Molecular basis of prodrug activation by human valacyclovirase, an α-amino acid ester hydrolase
Longsheng Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture
S. Biswas et al.
ARCHIVES OF VIROLOGY (2007)
Management of recurrent oral herpes simplex infections
Sook-Bin Woo et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2007)
On the mutation rate of herpes simplex virus type 1
JW Drake et al.
GENETICS (2005)
Characterization of herpes simplex virus type 1 thyraidine kinase mutants selected under a single round of high-dose brivudin
G Andrei et al.
JOURNAL OF VIROLOGY (2005)
A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2
KJ Looker et al.
SEXUALLY TRANSMITTED INFECTIONS (2005)
Isolation and characterization of herpes simplex virus type 1 resistant to arninothiazolylphenyl-based inhibitors of the viral helicase-primase
M Liuzzi et al.
ANTIVIRAL RESEARCH (2004)
Docosanol: a topical antiviral for herpes labialis
DT Leung et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia
SW Wassilew et al.
ANTIVIRAL RESEARCH (2003)
Herpes simplex virus resistance to antiviral drugs
F Morfin et al.
JOURNAL OF CLINICAL VIROLOGY (2003)
Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs
JF Marcelletti
ANTIVIRAL RESEARCH (2002)
Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms
C Gilbert et al.
DRUG RESISTANCE UPDATES (2002)
Cidofovir-induced end-stage renal failure
P Meier et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene
G Andrei et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Share Paper
